LU92903I2 - Gardasil-9/nom du produit:protéine hpv 52 l1 - Google Patents

Gardasil-9/nom du produit:protéine hpv 52 l1 Download PDF

Info

Publication number: LU92903I2
Authority: LU; Luxembourg
Prior art keywords: gardasil; product name; protein hpv; hpv; protein
Prior art date: 2004-03-24

Application number

LU92903C

Other languages

English (en)

French (fr)

Original Assignee

Merck Sharp & Dohme

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-03-24

Filing date

2015-12-08

Publication date

2016-03-08

2015-12-08 Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme

2016-03-08 Publication of LU92903I2 publication Critical patent/LU92903I2/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
- C07K14/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
- C12N7/045—Pseudoviral particles; Non infectious pseudovirions, e.g. genetically engineered
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Veterinary Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Biophysics (AREA)
Microbiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

LU92903C 2004-03-24 2015-12-08 Gardasil-9/nom du produit:protéine hpv 52 l1 LU92903I2 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US55592604P	2004-03-24	2004-03-24
PCT/US2005/009199 WO2005097821A1 (en)	2004-03-24	2005-03-18	Optimized expression of hpv 52 l1 in yeast
EP05725933A EP1730175B1 (en)	2004-03-24	2005-03-18	Optimized expression of hpv 52 l1 in yeast

Publications (1)

Publication Number	Publication Date
LU92903I2 true LU92903I2 (fr)	2016-03-08

Family

ID=34964085

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU92903C LU92903I2 (fr)	2004-03-24	2015-12-08	Gardasil-9/nom du produit:protéine hpv 52 l1

Country Status (31)

Country	Link
US (2)	US7700103B2 (el)
EP (1)	EP1730175B1 (el)
JP (1)	JP4833962B2 (el)
KR (1)	KR101203403B1 (el)
CN (1)	CN1934131B (el)
AR (1)	AR048191A1 (el)
AT (1)	ATE466022T1 (el)
AU (1)	AU2005230907C1 (el)
BE (1)	BE2015C066I2 (el)
BR (1)	BRPI0509079B8 (el)
CA (1)	CA2560487C (el)
CY (2)	CY1110349T1 (el)
DE (1)	DE602005020913D1 (el)
DK (1)	DK1730175T3 (el)
ES (1)	ES2343255T3 (el)
FR (1)	FR15C0085I2 (el)
HU (1)	HUS1500062I1 (el)
IL (1)	IL178140A (el)
LT (2)	LTPA2015050I1 (el)
LU (1)	LU92903I2 (el)
MY (1)	MY148656A (el)
NL (1)	NL300777I1 (el)
NO (3)	NO338055B1 (el)
NZ (1)	NZ549898A (el)
PL (1)	PL1730175T3 (el)
PT (1)	PT1730175E (el)
RU (1)	RU2373219C2 (el)
SI (1)	SI1730175T1 (el)
TW (1)	TWI349036B (el)
WO (1)	WO2005097821A1 (el)
ZA (1)	ZA200607575B (el)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7858098B2 (en) *	2002-12-20	2010-12-28	Glaxosmithkline Biologicals, S.A.	Vaccine
CN1869215B (zh) *	2006-05-19	2012-07-04	长春百克生物科技股份公司	一种制备人乳头瘤病毒的病毒样颗粒的方法
CA2679720A1 (en)	2007-03-09	2008-09-18	Merck & Co., Inc.	Papillomavirus vaccine compositions
CN101835797A (zh)	2007-11-23	2010-09-15	上海泽润生物科技有限公司	人乳头状瘤病毒主要衣壳蛋白l1基因及其用途
CN101440371B (zh) *	2007-11-23	2012-09-05	上海泽润生物科技有限公司	一种16型人乳头状瘤病毒主要衣壳蛋白l1基因
PL2569008T3 (pl) *	2010-05-14	2021-04-19	Baxalta Incorporated	Chimery ospa i ich zastosowanie w szczepionkach
CA2799205A1 (en)	2010-05-25	2011-12-01	Qiagen Gaithersburg, Inc.	Fast results hybrid capture assay and associated strategically-truncated probes
BR112013000031A2 (pt) *	2010-07-02	2016-05-10	Xiamen Innovax Biotech Co Ltd	proteína l1 hpv52 truncada ou variante da mesma, ácido nucleíco isolado, vetor, célula hospedeira, partícula do tipo viral hpv52, composição, composição farmacêutica ou vacina, método para obter uma proteína l1 hpv52 truncada, método para preparar a partícula do tipo viral hpv52, método para preparar uma vacina, método para prevenir a infecção hpv ou uma doença causada pela infecção de hpv e uso da proteína l1 hpv52 truncada ou variante da mesma
US8361720B2 (en)	2010-11-15	2013-01-29	Exact Sciences Corporation	Real time cleavage assay
CN103562392B (zh)	2010-12-03	2016-07-20	Ms技术有限责任公司	植物细胞中草甘膦抗性编码核酸分子的优化表达
CN102154325B (zh) *	2011-01-01	2013-08-21	上海生物制品研究所有限责任公司	针对人乳头瘤状病毒的疫苗及其制法和用途
RU2445357C1 (ru) *	2011-02-15	2012-03-20	Закрытое акционерное общество научно-производственная компания "Комбиотех"	Рекомбинантный штамм дрожжей pichia angusta - продуцент капсидного белка l1 вируса папилломы человека типа 16
RU2445358C1 (ru) *	2011-02-15	2012-03-20	Закрытое акционерное общество научно-производственная компания "Комбиотех"	Рекомбинантный штамм дрожжей pichia angusta - продуцент капсидного белка l1 вируса папилломы человека типа 18
CN110484554B (zh) *	2013-04-26	2024-04-16	北京安百胜生物科技有限公司	用汉逊酵母表达系统产生hpv52 l1蛋白的方法
CN110592133A (zh) *	2013-05-17	2019-12-20	北京安百胜生物科技有限公司	用汉逊酵母表达系统产生hpv31 l1蛋白的方法
WO2015057541A1 (en)	2013-10-16	2015-04-23	Merck Sharp & Dohme Corp.	Method of obtaining thermostable dried vaccine formulations
CN104878022A (zh) *	2015-04-27	2015-09-02	段青姣	编码hpv58l1、hpv52l1蛋白的核苷酸序列及其应用
CN106701796B (zh) *	2015-08-12	2021-11-16	北京康乐卫士生物技术股份有限公司	52型重组人乳头瘤病毒病毒样颗粒及其制备方法
CN109750049B (zh) *	2017-11-07	2023-08-18	上海泽润生物科技有限公司	重组人乳头瘤病毒52亚型蛋白表达
CA3166256A1 (en)	2020-02-14	2021-08-19	Marian E. Gindy	Human papillomavirus (hpv) virus-like particles (vlps) vaccine
CN114539365B (zh) *	2020-11-26	2023-12-01	中国医学科学院基础医学研究所	一种改造的人乳头瘤病毒52型l1蛋白及其用途
CN113073105B (zh) *	2021-03-23	2023-06-13	重庆博唯佰泰生物制药有限公司	一种表达hpv 56l1的多核苷酸序列及其表达载体、宿主细胞和应用
CN113549634B (zh) *	2021-06-07	2023-03-31	郑州大学	编码可溶性hpv58 l1蛋白的基因及其重组质粒的构建与应用
US20230048144A1 (en)	2021-08-06	2023-02-16	Merck Sharp & Dohme Llc	Hpv vaccine
AR126813A1 (es)	2021-08-19	2023-11-15	Merck Sharp & Dohme Llc	Nueva nanopartícula lipídica termostable y métodos de uso de la misma

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1339729C (en) *	1988-10-26	1998-03-17	Wayne D. Lancaster	Human papillomavirus type 52 dna sequences and methods for employing thesame
IL117591A0 (en) *	1995-03-30	1996-07-23	Merck & Co Inc	Synthetic DNA encoding human papillomavirus type 11 L1 protein
US5821087A (en) *	1995-03-30	1998-10-13	Merck & Co., Inc.	Production of recombinant human papillomavirus type II protein utilizing papillomavirus 6/11 hybrid DNA
IL131131A0 (en)	1997-02-07	2001-01-28	Merck & Co Inc	Synthetic hiv gag genes
CA2296067C (en)	1997-07-09	2008-10-07	The University Of Queensland	Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue
JP4563582B2 (ja)	1998-08-14	2010-10-13	メルク・シャープ・エンド・ドーム・コーポレイション	ヒトパピローマウイルスのウイルス様粒子を使用するタンパク質送達系
WO2000009671A1 (en) *	1998-08-14	2000-02-24	Merck & Co., Inc.	Process for purifying human papillomavirus virus-like particles
SE514982C2 (sv) *	1999-09-30	2001-05-28	Active Biotech Ab	Bärare innehållande ett huvudkapsidprotein L1 från humant papillomavirus samt dess användning
EP1212358B1 (en)	1999-08-25	2004-12-15	Merck & Co., Inc.	Synthetic papillomavirus genes optimized for expression in human cells
US6436402B1 (en)	1999-10-15	2002-08-20	Merck & Co., Inc.	Process for making human papillomavirus virus-like particles with improved properties
HUP0300745A3 (en)	2000-07-21	2010-01-28	Glaxo Group Ltd	Codon-optimized papilloma virus sequences
US20030226155A1 (en) *	2001-08-30	2003-12-04	Biorexis Pharmaceutical Corporation	Modified transferrin-antibody fusion proteins
NZ542246A (en) *	2003-03-24	2007-12-21	Merck & Co Inc	Optimized expression of HPV 31 L1 yeast
MY140664A (en)	2003-09-29	2010-01-15	Merck Sharp & Dohme	Optimized expression of hpv 45 l1 in yeast
MY139500A (en)	2003-11-12	2009-10-30	Merck Sharp & Dohme	Optimized expression of hpv 58 l1 in yeast

2005
- 2005-03-18 US US10/594,064 patent/US7700103B2/en active Active
- 2005-03-18 DK DK05725933.5T patent/DK1730175T3/da active
- 2005-03-18 DE DE602005020913T patent/DE602005020913D1/de active Active
- 2005-03-18 BR BRPI0509079A patent/BRPI0509079B8/pt active IP Right Grant
- 2005-03-18 ES ES05725933T patent/ES2343255T3/es active Active
- 2005-03-18 RU RU2006137363/13A patent/RU2373219C2/ru active
- 2005-03-18 AU AU2005230907A patent/AU2005230907C1/en active Active
- 2005-03-18 PL PL05725933T patent/PL1730175T3/pl unknown
- 2005-03-18 EP EP05725933A patent/EP1730175B1/en active Active
- 2005-03-18 JP JP2007505032A patent/JP4833962B2/ja active Active
- 2005-03-18 SI SI200531052T patent/SI1730175T1/sl unknown
- 2005-03-18 KR KR1020067019673A patent/KR101203403B1/ko active IP Right Grant
- 2005-03-18 TW TW094108431A patent/TWI349036B/zh active
- 2005-03-18 CN CN2005800095956A patent/CN1934131B/zh active Active
- 2005-03-18 MY MYPI20051180A patent/MY148656A/en unknown
- 2005-03-18 NZ NZ549898A patent/NZ549898A/en unknown
- 2005-03-18 AT AT05725933T patent/ATE466022T1/de active
- 2005-03-18 WO PCT/US2005/009199 patent/WO2005097821A1/en active Application Filing
- 2005-03-18 CA CA2560487A patent/CA2560487C/en active Active
- 2005-03-18 PT PT05725933T patent/PT1730175E/pt unknown
- 2005-03-23 AR ARP050101174A patent/AR048191A1/es active IP Right Grant
2006
- 2006-09-11 ZA ZA200607575A patent/ZA200607575B/xx unknown
- 2006-09-17 IL IL178140A patent/IL178140A/en active IP Right Grant
- 2006-10-23 NO NO20064815A patent/NO338055B1/no active Protection Beyond IP Right Term
2009
- 2009-10-14 US US12/578,995 patent/US7744892B2/en active Active
2010
- 2010-07-26 CY CY20101100698T patent/CY1110349T1/el unknown
2015
- 2015-11-30 NL NL300777C patent/NL300777I1/nl unknown
- 2015-12-02 HU HUS1500062C patent/HUS1500062I1/hu unknown
- 2015-12-04 FR FR15C0085C patent/FR15C0085I2/fr active Active
- 2015-12-07 CY CY2015052C patent/CY2015052I1/el unknown
- 2015-12-08 LT LTPA2015050D patent/LTPA2015050I1/lt unknown
- 2015-12-08 LU LU92903C patent/LU92903I2/xx unknown
- 2015-12-08 LT LTPA2015050C patent/LTC1730175I2/lt unknown
- 2015-12-09 BE BE2015C066C patent/BE2015C066I2/nl unknown
2017
- 2017-01-20 NO NO2017005C patent/NO2017005I1/no unknown
2022
- 2022-11-30 NO NO2022050C patent/NO2022050I1/no unknown

Also Published As

Publication number	Publication date
KR101203403B1 (ko)	2012-11-21
SI1730175T1 (sl)	2010-08-31
CA2560487A1 (en)	2005-10-20
AR048191A1 (es)	2006-04-05
PL1730175T3 (pl)	2010-09-30
CN1934131A (zh)	2007-03-21
KR20060134120A (ko)	2006-12-27
TWI349036B (en)	2011-09-21
IL178140A0 (en)	2006-12-31
RU2373219C2 (ru)	2009-11-20
FR15C0085I1 (el)	2016-08-01
IL178140A (en)	2010-11-30
US7744892B2 (en)	2010-06-29
LTPA2015050I1 (lt)	2016-01-11
NO338055B1 (no)	2016-07-25
AU2005230907B2 (en)	2011-05-19
WO2005097821A1 (en)	2005-10-20
NO2017005I1 (no)	2017-01-20
EP1730175A1 (en)	2006-12-13
US7700103B2 (en)	2010-04-20
AU2005230907A1 (en)	2005-10-20
JP2007530040A (ja)	2007-11-01
NO2022050I1 (no)	2022-11-30
US20080226660A1 (en)	2008-09-18
JP4833962B2 (ja)	2011-12-07
HUS1500062I1 (hu)	2017-07-28
CY2015052I2 (el)	2016-06-22
TW200602490A (en)	2006-01-16
CY2015052I1 (el)	2016-06-22
CN1934131B (zh)	2010-12-29
NL300777I2 (el)	2015-12-29
NZ549898A (en)	2009-06-26
MY148656A (en)	2013-05-15
LTC1730175I2 (lt)	2017-05-10
CY1110349T1 (el)	2015-04-29
CA2560487C (en)	2013-01-29
NL300777I1 (el)	2015-12-29
AU2005230907C1 (en)	2016-07-28
ZA200607575B (en)	2008-08-27
NO20064815L (no)	2006-10-23
RU2006137363A (ru)	2008-04-27
BRPI0509079B1 (pt)	2020-05-19
DK1730175T3 (da)	2010-08-23
BE2015C066I2 (el)	2024-08-08
ES2343255T3 (es)	2010-07-27
EP1730175B1 (en)	2010-04-28
US20100035818A1 (en)	2010-02-11
PT1730175E (pt)	2010-06-25
BRPI0509079B8 (pt)	2021-07-06
DE602005020913D1 (de)	2010-06-10
FR15C0085I2 (fr)	2016-11-25
BRPI0509079A (pt)	2007-08-21
ATE466022T1 (de)	2010-05-15

Publication	Publication Date	Title
LU92903I2 (fr)	2016-03-08	Gardasil-9/nom du produit:protéine hpv 52 l1
LU92902I2 (fr)	2016-03-08	Gardasil-9/nom du produit: protéine hpv 45 l1
LU92901I2 (fr)	2016-03-08	Gardasil-9/ nom du produit: protéine hpv58l1
DE602004012052D1 (de)	2008-04-10	Akustisch gekoppelter Produktaufkleber
DE602004029184D1 (de)	2010-10-28	Einwegscheuerprodukt
FR2838048B1 (fr)	2005-05-27	Produit dentaire reticulable/dereticulable
LU92898I2 (fr)	2016-03-08	Gardasil-9/vaccination contre les stéréotypes 16,18 et 31 nom de produit: hpv l1 vlps 16+18+31
FIU20070081U0 (fi)	2007-03-01	Saniteettituote
FR2877842B1 (fr)	2008-12-12	Produit aerosol anti-transpirant
SE0301552L (sv)	2004-11-28	New product
SE0300002L (sv)	2004-07-04	Ny produkt
DE502005003152D1 (de)	2008-04-24	Produktbehälter
DK1691751T3 (da)	2011-09-26	Hygiejneprodukt
FR2850973B1 (fr)	2007-04-20	Produit bi-composant
FR2873312B1 (fr)	2008-05-23	Produit pour biotraitement environnemental
FR2856994B1 (fr)	2005-09-09	Ensemble de distribution de produit
FR2892012B1 (fr)	2008-07-18	Procede d'epilation
FR2865432B1 (fr)	2008-04-11	Materiau d'operculage ludique
ATE374761T1 (de)	2007-10-15	Syntheseverfahren und benzoxathiepinzwischenprodukte
FR2871690B3 (fr)	2006-05-12	Produit cosmetique antirides
ITBG20040037A1 (it)	2004-12-17	Prodotto dolciario
ITMO20050281A1 (it)	2007-04-27	Prodotto dolciario
UA10221S (uk)	2005-05-16	Гігієнічний виріб
UA8093S (uk)	2003-10-15	Етикетка для молочних виробів
FR2889913B1 (fr)	2007-11-23	Ensemble d'allumettes